主题分布
Pain (8; 22%)
Fentanyl (7; 19%)
Analgesics, Opioid (4; 11%)
therapeutic use * (4; 11%)
Neoplasms (4; 11%)
Etiology (2; 5%)
complications * (2; 5%)
classification (2; 5%)
drug therapy * (2; 5%)
Humans (2; 5%)
出版年分布
2025 (0; 0%)
2024 (0; 0%)
2023 (0; 0%)
2022 (0; 0%)
2021 (0; 0%)
2020 (0; 0%)
2019 (1; 25%)
2018 (0; 0%)
2017 (1; 25%)
2016 (0; 0%)
出版社分布
Scholars' Press (1; 33%)
Project Gutenberg (1; 33%)
L'Erma di Bretschneider (1; 33%)
馆藏分布
哥伦比亚大学 (1; 100%)
Fentanyl
癌症相关的突破性疼痛
ISBN:9780198840480,出版年:2019,中图分类号:R5 被引 93次

Breakthrough pain is a common problem in patients with cancer, and is associated with significant morbidity among this group of patients. This review examines the different types of breakthrough pain, and the various options for the management of breakthrough pain.

ISBN:E100000039745,出版年:2012,中图分类号:I

快速作用芬太尼制剂在癌症突破性疼痛中的应用。
ISBN:9786202304405,出版年:2017,中图分类号:R73

A rational and transparent method, System of Objectified Judgement Analysis (SOJA), for drug selection is described for selection of rapid acting fentanyl formulations for breakthrough pain in cancer-related pain. The relevant selection criteria for a group of drugs are defined and judged by a panel of experts. The more important that a selection criterion is considered, the higher the relative weight that is given to that criterion. The ideal properties for each selection criterion are determined and each drug is scored as a percentage of the relative weight for all selection criteria. Selection criteria (relative weight) were: number of available strengths (60), variability in rate of absorption (50), interactions (50), clinical efficacy (350), side-effects (150), ease of administration (140) and documentation (200). The sublingual fentanyl orally disintegrating tablet (Abstral) showed the highest overall score, followed by the nasal sprays (Instanyl and PecFent). These are the most attractive formulations from a formulary perspective.

奥维托。克劳迪奥·法伊纳博物馆,1
ISBN:9788870620412,出版年:1969,中图分类号:G1

  • 1